Llwytho...
LRRK2 and ubiquitination: implications for kinase inhibitor therapy
Pathogenic mutations and risk variants in LRRK2 (leucine-rich repeat kinase 2) represent the most common genetic cause of familial and sporadic PD (Parkinson's disease). LRRK2 protein is widely expressed throughout the brain and the periphery. Structurally, LRRK2 contains several functional dom...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Biochem J |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Portland Press Ltd.
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613699/ https://ncbi.nlm.nih.gov/pubmed/26341487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20150785 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|